Cryptogenic organizing pneumonia causes
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia causes On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia causes |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2] Serge Korjian M.D.
Overview
Cryptogenic organizing pneumonia has no identifiable etiology. Some of the causes of organizing pneumonia include infectious agents, drugs, inflammatory diseases, and toxic exposures.
Causes
Some of the causes of organizing pneumonia include infectious agents, drugs, inflammatory diseases, and toxic exposures.
Infectious agents
- Chlamydia pneumoniae
- Coxiella burnetii
- Cryptococcus neoformans
- Herpes virus
- Human immunodeficiency virus
- Influenza virus
- Legionella pneumophila
- Mycoplasma pneumoniae
- Nocardia asteroides
- Parainfluenza virus
- Penicillium janthinellum
- Plasmodium vivax
- Pneumocystis carinii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Streptococcus group B
- Streptococcus pneumoniae[1]
Drugs
- Acebutolol
- Amiodarone
- Amphotericin B
- Atorvastatin
- Azacytidine
- Azathioprine
- Betaxolol
- Bleomycin
- Bortezomib
- Bucillamine
- Busulfan
- Carbamazepine
- Cephalexin
- Chlorambucil
- Cladribine
- Clomipramine
- Cocaine
- Crizotinib
- Cyclophosphamide
- Cytarabine
- Daptomycin
- Doxorubicin
- Dronedarone
- Drug-eluting stents
- Ergot alkaloids
- Erlotinib
- Etanercept
- Everolimus
- Fludarabine
- Fosinopril
- Gold (chrysotherapy)
- Heroin (injected)
- Hexamethonium
- Hydralazine
- Hydroxyurea
- Imatinib
- Imipramine
- Infliximab
- Interferon-alpha/beta
- Ipilimumab
- Leflunomide
- Lenalidomide
- Loxoprofen
- Mecamylamine
- Mesalazine (5-aminosalicylate)
- Methotrexate
- Minocycline
- Nilutamide
- Nitrofurantoin
- Oxaliplatin
- Penicillamine
- Phenytoin (diphenylhydantoin)
- Pravastatin
- Propylthiouracil (PTU)
- Quinine
- Risedronate
- Rituximab
- Sertraline
- Simvastatin
- Sirolimus
- Sotalol
- Sulfasalazine
- Sulindac
- Tacrolimus
- Temozolomide
- Thalidomide
- Ticlopidine
- Timolol
- Tocilizumab
- Topotecan
- Trastuzumab
- Tryptophan[2]
Inflammatory diseases
Toxic exposures[2]
References
- ↑ Cordier JF (2000). "Organising pneumonia". Thorax. 55 (4): 318–28. PMC 1745738. PMID 10722773.
- ↑ 2.0 2.1 Organizing pneumonia (OP/BOOP). Pneumotox.com, The Drug-Induced Respiratory Disease Website. Available at http://www.pneumotox.com/pattern/view/5/I.d/organizing-pneumonia-op-boop/. Accessed on February 1, 2016.